These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 9577743)
41. Discrepancy rate in biopsy and cytology reports. Elliott WG Am J Clin Pathol; 1996 Mar; 105(3):371. PubMed ID: 8602620 [No Abstract] [Full Text] [Related]
42. Transitional cell metaplasia of the cervix: a newly described entity in cervicovaginal smears. Weir MM; Bell DA Diagn Cytopathol; 1998 Mar; 18(3):222-6. PubMed ID: 9523143 [TBL] [Abstract][Full Text] [Related]
43. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049 [TBL] [Abstract][Full Text] [Related]
44. Microglandular endocervical hyperplasia and tubal metaplasia: pitfalls in the diagnosis of adenocarcinoma on cervical smears. Selvaggi SM; Haefner HK Diagn Cytopathol; 1997 Feb; 16(2):168-73. PubMed ID: 9067112 [TBL] [Abstract][Full Text] [Related]
45. By the way, doctor. I'm 48 years old, and 26 years ago I had a cone biopsy after an abnormal Pap test. Since then, all my Pap tests have been normal. But for the past three years, scar tissue has made it difficult for my gynecologist to get adequate cells. What do I do about Pap smears now? Robb-Nicholson C Harv Womens Health Watch; 2006 Aug; 13(12):8. PubMed ID: 17117509 [No Abstract] [Full Text] [Related]
47. Squamous atypia in the atrophic cervical vaginal smear: a plea for a more painstaking old style look versus a new look at the old problem. Medley G; Surtees VM Cancer; 1998 Aug; 84(4):200-1. PubMed ID: 9723593 [No Abstract] [Full Text] [Related]
48. The effects of different sampling techniques on smear quality and the diagnosis of cytological abnormalities in cervical screening. Williamson SL; Hair T; Wadehra V Cytopathology; 1997 Jun; 8(3):188-95. PubMed ID: 9202894 [TBL] [Abstract][Full Text] [Related]
49. Quality assurance in cervical cytology. The Papanicolaou smear. Council on Scientific Affairs. JAMA; 1989 Sep 22-29; 262(12):1672-9. PubMed ID: 2671421 [No Abstract] [Full Text] [Related]
50. Correlation of cervical cytodiagnosis and histopathology--an exercise in quality control. Kealy WF Ir J Med Sci; 1986 Nov; 155(11):381-8. PubMed ID: 3804671 [No Abstract] [Full Text] [Related]
51. Management of the abnormal Papanicolaou smear. Appleby J Med Clin North Am; 1995 Mar; 79(2):345-60. PubMed ID: 7877395 [TBL] [Abstract][Full Text] [Related]
52. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. Sankaranarayanan R; Shyamalakumary B; Wesley R; Sreedevi Amma N; Parkin DM; Nair MK Int J Cancer; 1999 Jan; 80(1):161-3. PubMed ID: 9935247 [No Abstract] [Full Text] [Related]
53. [The quality of a cervix smear]. Linthorst G; van Lindert AC Ned Tijdschr Geneeskd; 1978 Aug; 122(33):1231-2. PubMed ID: 673061 [No Abstract] [Full Text] [Related]
54. Squamous metaplastic cells in cervical canal aspiration smears in women with ovarian function disorders. Stanek J; Walas-Skolicka E Arch Geschwulstforsch; 1977; 47(5):440-3. PubMed ID: 73365 [TBL] [Abstract][Full Text] [Related]
55. Management of cervical dyskaryosis. National guidelines are not followed. Saha A; Maresh M BMJ; 1994 Jul; 309(6949):268. PubMed ID: 8069149 [No Abstract] [Full Text] [Related]
58. Papanicolaou tests: does lubricant reduce the quality or adequacy? Allan GM; Korownyk C; Ivers N Can Fam Physician; 2011 Mar; 57(3):309. PubMed ID: 21402967 [No Abstract] [Full Text] [Related]
59. Intraobserver and interobserver variability in the diagnosis of epithelial abnormalities in cervical smears. Klinkhamer PJ; Vooijs GP; de Haan AF Acta Cytol; 1988; 32(6):794-800. PubMed ID: 3201873 [TBL] [Abstract][Full Text] [Related]